Neuroleptic malignant syndrome and hypothyroidism.
AUTOR(ES)
Moore, A P
RESUMO
Two patients with primary hypothyroidism who developed neuroleptic malignant syndrome (NMS) are described. Thyroid disease might predispose to NMS by altering brain dopamine metabolism.